One study showed more than a 600% increased risk of blood clots for women taking COCPs with drospirenone compared with non-users, compared with 360% higher for women taking birth control pills containing levonorgestrel.  The . Food and Drug Administration (FDA) initiated studies evaluating the health of more than 800,000 women taking COCPs and found that the risk of VTE was 93% higher for women who had been taking drospirenone COCPs for 3 months or less and 290% higher for women taking drospirenone COCPs for 7–12 months, compared with women taking other types of oral contraceptives. 
The Oral Cancer Walk & 5K has been an annual tradition at Penn since 2009. It is created and organized entirely by students. Our mission is to raise awareness about oral cancer.
We organize a variety of fundraising activities leading up to our annual race in the Spring.
On race day, after seeing all our runners and walkers through the finish line, we provide free oral cancer screenings, hear from our organizers, advisors and speakers, and raffle off great prizes! ...
100% of the proceeds from fundraisers and the Walk/5K are donated to The Oral Cancer Foundation.